Twin Tree Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Sell
3,400
-9,600
-74% -$9.73M 0.07% 339
2025
Q4
$14M Sell
13,000
-38,800
-75% -$37.1M 0.12% 206
2025
Q3
$39.5M Sell
51,800
-46,300
-47% -$34.5M 0.16% 120
2025
Q2
$76.5M Sell
98,100
-99,300
-50% -$77.2M 0.14% 143
2025
Q1
$163M Buy
197,400
+173,000
+709% +$144M 0.31% 33
2024
Q4
$18.8M Buy
24,400
+14,100
+137% +$11.7M 0.03% 485
2024
Q3
$9.13M Sell
10,300
-10,100
-50% -$9.08M 0.02% 690
2024
Q2
$18.5M Sell
20,400
-4,500
-18% -$3.6M 0.04% 392
2024
Q1
$19.4M Buy
24,900
+5,900
+31% +$4.2M 0.04% 416
2023
Q4
$11.1M Buy
+19,000
New +$11.1M 0.02% 663
2023
Q2
Sell
-8,700
Closed -$2.99M 1399
2023
Q1
$2.99M Buy
+8,700
New +$2.93M 0.01% 840
2022
Q4
Sell
-78,200
Closed -$25.3M 1443
2022
Q3
$25.3M Buy
+78,200
New +$24.8M 0.05% 323
2022
Q2
Sell
-14,400
Closed -$4.12M 1701
2022
Q1
$4.12M Sell
14,400
-36,500
-72% -$9.39M 0.01% 986
2021
Q4
$14.1M Sell
50,900
-109,000
-68% -$27.6M 0.03% 519
2021
Q3
$36.9M Buy
159,900
+98,000
+158% +$24.2M 0.08% 229
2021
Q2
$14.2M Buy
61,900
+13,200
+27% +$2.65M 0.04% 415
2021
Q1
$9.1M Buy
+48,700
New +$9.53M 0.03% 481
2020
Q4
Sell
-10,800
Closed -$1.6M 1391
2020
Q3
$1.6M Sell
10,800
-175,400
-94% -$27.1M 0.01% 803
2020
Q2
$30.6M Buy
186,200
+64,200
+53% +$9.85M 0.12% 184
2020
Q1
$16.9M Sell
122,000
-43,700
-26% -$6M 0.08% 218
2019
Q4
$21.8M Buy
165,700
+54,100
+48% +$6.27M 0.08% 211
2019
Q3
$12.5M Buy
+111,600
New +$12.4M 0.05% 266
2019
Q2
Sell
-4,500
Closed -$584K 1425
2019
Q1
$584K Buy
+4,500
New +$547K ﹤0.01% 930
2018
Q4
Sell
-13,300
Closed -$1.43M 1436
2018
Q3
$1.43M Buy
+13,300
New +$1.33M 0.01% 659
2017
Q3
Sell
-36,700
Closed -$3.02M 1081
2017
Q2
$3.02M Buy
36,700
+26,700
+267% +$2.18M 0.02% 481
2017
Q1
$841K Sell
10,000
-138,800
-93% -$11.1M 0.01% 712
2016
Q4
$10.9M Buy
148,800
+85,700
+136% +$6.38M 0.11% 224
2016
Q3
$5.06M Buy
63,100
+7,500
+13% +$600K 0.06% 278
2016
Q2
$4.38M Buy
55,600
+46,400
+504% +$3.49M 0.07% 291
2016
Q1
$662K Sell
9,200
-37,100
-80% -$2.81M 0.01% 725
2015
Q4
$3.9M Buy
46,300
+16,700
+56% +$1.39M 0.08% 243
2015
Q3
$2.48M Sell
29,600
-6,700
-18% -$566K 0.06% 294
2015
Q2
$3.03M Buy
36,300
+14,800
+69% +$1.13M 0.07% 273
2015
Q1
$1.56M Sell
21,500
-14,600
-40% -$1.04M 0.04% 462
2014
Q4
$2.49M Sell
36,100
-13,300
-27% -$898K 0.07% 314
2014
Q3
$3.2M Sell
49,400
-104,700
-68% -$6.63M 0.09% 257
2014
Q2
$9.58M Buy
154,100
+108,400
+237% +$6.47M 0.22% 78
2014
Q1
$2.69M Sell
45,700
-59,800
-57% -$3.34M 0.05% 377
2013
Q4
$5.38M Buy
105,500
+23,300
+28% +$1.17M 0.13% 154
2013
Q3
$4.14M Buy
82,200
+56,000
+214% +$2.93M 0.14% 151
2013
Q2
$1.29M Buy
+26,200
New +$1.43M 0.05% 408

Other funds holding LLY

Twin Tree Management's LLY Position: Q4 2025 in Review

Twin Tree Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 16,206 shares — an estimated $15.5M sold.

Twin Tree Management first reported a position in LLY in Q2 2013 and held it in 33 quarters. The position peaked at $48.3M in Q3 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Twin Tree Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 16,206 Eli Lilly shares in Q4 2025, an estimated $15.5M.
  • Twin Tree Management first reported a position in Eli Lilly in Q2 2013 and held it in 33 quarters.
  • Twin Tree Management's Eli Lilly position peaked at $48.3M in Q3 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.